Mediveine (Diosmin)

Diosmin is converted to diosmetin after oral absorption. The metabolite strengthens venous wall contractility, lowers capillary permeability, and provides anti‑inflammatory and antioxidant effects. These actions improve venous return and reduce fluid buildup in the affected tissues.

The appropriate dose of Mediveine is determined by the prescribing healthcare professional based on the individual’s condition, severity, and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for diosmin in pregnancy and lactation are limited. It should only be used when the potential benefit justifies any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with synthetic venotonic drugs, diosmin is a natural flavonoid with a well‑documented safety profile. It offers similar efficacy in reducing venous symptoms but may have fewer systemic side effects. Clinical choice depends on patient tolerance, comorbidities, and physician preference.

Mediveine should be stored at room temperature below 25 °C. Keep the product in its original packaging, protect it from moisture and direct light, and ensure the container is tightly closed to maintain stability.

Mediveine is taken orally, usually with water. The tablet (or other oral form) should be swallowed whole and not crushed or chewed unless otherwise directed by a healthcare professional.

Serious adverse reactions, although rare, include severe allergic responses such as anaphylaxis, Stevens‑Johnson syndrome, hepatic dysfunction, and significant thrombocytopenia. Patients should seek immediate medical attention if they experience signs of a severe reaction.

Mediveine is contraindicated in individuals with known hypersensitivity to diosmin or any other flavonoid components. Patients on anticoagulant therapy, those with severe liver disease, or those who have experienced serious allergic reactions to similar agents should avoid its use unless advised otherwise by a physician.